IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Medical Research

• Publication date

  2004-10-29

• Fields of study

  Medicine

• Identifiers
  PMID 15546815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin for treating sepsis and septic shock.

  2002cited by this paper
• Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

  2002cited by this paper
• Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

  2002cited by this paper
• Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients

  2002cited by this paper
• Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins.

  2001influential reference
• Adjuvante Sepsistherapie mit polyvalenten Immunglobulinen. Eine prospektive Beobachtungsstudie / Adjuvant Sepsis Therapy with Polyvalant Immunoglobulines: A Prospective Valuation

  2001cited by this paper
• Intravenous immunoglobulin for treating sepsis and septic shock.

  2000cited by this paper
• Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery.

  1999cited by this paper
• Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

  1999cited by this paper
• Peritonitis-Monitoring mit Procalcitonin und Diagnostik von Immunfunktionsstörungen durch HLA-DR-Expression auf Monozyten

  1999cited by this paper
• In vitro inhibitory activity of tumor necrosis factor alpha and interleukin-2 of human immunoglobulin preparations.

  1997cited by this paper
• Sepsis: a new hypothesis for pathogenesis of the disease process.

  1997cited by this paper
• Scoringsysteme bei Peritonitis und Sepsis – ein prognostisches Hilfsmittel

  1997cited by this paper
• Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.

  1997cited by this paper
• Immunotherapeutic approaches of severe sepsis and septic shock: where are we, and where do we go from here?

  1997cited by this paper
• The systemic inflammatory response in the development of ventilator-associated pneumonia.

  1997cited by this paper
• Cytokines as mediators in the pathogenesis of septic shock.

  1996cited by this paper
• Determination of endotoxin-neutralizing capacity of plasma in postsurgical patients.

  1996cited by this paper
• High-dose intravenous IgG for treatment of severe surgical infections

  1996cited by this paper
• Prediction of outcome using the Mannheim peritonitis index in 2003 patients

  1994cited by this paper
• Compartmentalized cytokine production within the human lung in unilateral pneumonia.

  1994cited by this paper
• Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group.

  1994cited by this paper
• Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection.

  1992cited by this paper
• Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial.

  1992cited by this paper
• Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins

  1992cited by this paper
• Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells.

  1991cited by this paper
• Treatment of Gram‐negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial

  1991cited by this paper
• Human intravenous immunoglobulin modulates monokine production in vitro.

  1990cited by this paper
• Cooperative group of additional immunoglobulin therapy in severe bacterial infections: Results of a multicenter randomized controlled trial in cases of diffuse fibrinopurulent peritonitis

  1987cited by this paper
• Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation.

  1986cited by this paper
• APACHE II--a severity of disease classification system.

  1986cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma

  1985cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• Synergy between acylureidopenicillins and immunoglobulin G in experimental animals.

  1984cited by this paper

• Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections—Interactions with Neutrophils, Complement, and Coagulation Pathways

  2023influential citation
• The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial

  2023cites this paper
• Effect of the Immunoglobulin G-A-M Treatment on Hepatic Functions and Mortality rates in Patients with Septic Shock

  2022cites this paper
• “Impact of pentaglobin in severe COVID 19 pneumonia- a prospective study.”

  2021cites this paper
• ARCHIVES OF CURRENT MEDICAL RESEARCH

  2021cites this paper
• Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis

  2020cites this paper
• PCT

  2019cites this paper
• Adjuvant therapy in septic neonates with immunoglobulin preparationscontaining Ig isotypes in addition to IgG: A critical review of currentliterature.

  2017cites this paper
• Role of immunoglobulins in neonatal sepsis

  2014cites this paper
• An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

  2012cites this paper
• Timing IgM Treatment in Sepsis: Is Procalcitonin the Answer?

  2012cites this paper
• Клинические аспекты патогенетических влияний, определяющих состояние иммунной системы у пациентов с ургентной

  2011cites this paper
• Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock *

  2007cites this paper
• IMMUNOGLOBULIN M-ENRICHED HUMAN INTRAVENOUS IMMUNOGLOBULINS REDUCE LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS AND ATTENUATE MICROVASCULAR PERFUSION FAILURE IN NORMOTENSIVE ENDOTOXEMIA

  2007cites this paper
• A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens.

  2006cites this paper